Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mireia Molina van den Bosch

Showing results (1-10 of 9) with videos related to

Pageof 1
Sort By:
Trends in Endocrinology and Metabolism: TEM|May 18, 2026
From architecture to function: mechanisms shaping pancreatic islet morphogenesisMireia Molina van den Bosch, Tobias Greisle, Christos Karampelias, et al.
Biomolecules|January 21, 2022
Antioxidant Roles of SGLT2 Inhibitors in the KidneyCarmen Llorens-Cebrià, Mireia Molina-Van den Bosch, Ander Vergara, et al.
International Journal of Molecular Sciences|May 23, 2020
Revisiting Experimental Models of Diabetic NephropathyAnna Giralt-López, Mireia Molina-Van den Bosch, Ander Vergara, et al.
Molecular and Cellular Endocrinology|April 3, 2021
Effect of ramipril on kidney, lung and heart ACE2 in a diabetic mice modelAnder Vergara, Conxita Jacobs-Cachá, Mireia Molina-Van den Bosch, et al.
Cells|February 25, 2022
Asymptomatic Hyperuricemia Promotes Recovery from Ischemic Organ Injury by Modulating the Phenotype of MacrophagesViviane Gnemmi, Qiubo Li, Qiuyue Ma, et al.
EMBO Molecular Medicine|November 4, 2025
Benchmarking porcine pancreatic ductal organoids for drug screening applicationsChristos Karampelias, Kaiyuan Yang, Falk J Farkas, et al.
International Journal of Molecular Sciences|November 11, 2022
Enhanced Cardiorenal Protective Effects of Combining SGLT2 Inhibition, Endothelin Receptor Antagonism and RAS Blockade in Type 2 Diabetic MiceAnder Vergara, Conxita Jacobs-Cacha, Carmen Llorens-Cebria, et al.
Journal of Clinical Medicine|July 24, 2021
The Impact of Age on Mortality in Chronic Haemodialysis Popu-Lation with COVID-19Ander Vergara, Mireia Molina-Van den Bosch, Néstor Toapanta, et al.
Clinical Science (London, England : 1979)|December 16, 2022
The membrane-associated protein 17 (MAP17) is up-regulated in response to empagliflozin on top of RAS blockade in experimental diabetic nephropathyAnder Vergara, Carmen Llorens-Cebrià, Nerea Martos, et al.
Pageof 1

Showing results (1-10 of 9) with videos related to

Sort By:
Pageof 1
Trends in Endocrinology and Metabolism: TEM|May 18, 2026
From architecture to function: mechanisms shaping pancreatic islet morphogenesisMireia Molina van den Bosch, Tobias Greisle, Christos Karampelias, et al.
Biomolecules|January 21, 2022
Antioxidant Roles of SGLT2 Inhibitors in the KidneyCarmen Llorens-Cebrià, Mireia Molina-Van den Bosch, Ander Vergara, et al.
International Journal of Molecular Sciences|May 23, 2020
Revisiting Experimental Models of Diabetic NephropathyAnna Giralt-López, Mireia Molina-Van den Bosch, Ander Vergara, et al.
Molecular and Cellular Endocrinology|April 3, 2021
Effect of ramipril on kidney, lung and heart ACE2 in a diabetic mice modelAnder Vergara, Conxita Jacobs-Cachá, Mireia Molina-Van den Bosch, et al.
Cells|February 25, 2022
Asymptomatic Hyperuricemia Promotes Recovery from Ischemic Organ Injury by Modulating the Phenotype of MacrophagesViviane Gnemmi, Qiubo Li, Qiuyue Ma, et al.
EMBO Molecular Medicine|November 4, 2025
Benchmarking porcine pancreatic ductal organoids for drug screening applicationsChristos Karampelias, Kaiyuan Yang, Falk J Farkas, et al.
International Journal of Molecular Sciences|November 11, 2022
Enhanced Cardiorenal Protective Effects of Combining SGLT2 Inhibition, Endothelin Receptor Antagonism and RAS Blockade in Type 2 Diabetic MiceAnder Vergara, Conxita Jacobs-Cacha, Carmen Llorens-Cebria, et al.
Journal of Clinical Medicine|July 24, 2021
The Impact of Age on Mortality in Chronic Haemodialysis Popu-Lation with COVID-19Ander Vergara, Mireia Molina-Van den Bosch, Néstor Toapanta, et al.
Clinical Science (London, England : 1979)|December 16, 2022
The membrane-associated protein 17 (MAP17) is up-regulated in response to empagliflozin on top of RAS blockade in experimental diabetic nephropathyAnder Vergara, Carmen Llorens-Cebrià, Nerea Martos, et al.
Pageof 1